Hastings Karen Taraszka
Department of Basic Medical Sciences, University of Arizona College of Medicine , Phoenix, AZ , USA.
Front Immunol. 2013 Dec 4;4:429. doi: 10.3389/fimmu.2013.00429.
The MHC class II-restricted antigen processing pathway generates peptide:MHC complexes in the endocytic pathway for the activation of CD4(+) T cells. Gamma-interferon-inducible lysosomal thiol reductase (GILT) reduces protein disulfide bonds in the endocytic compartment, thereby exposing buried epitopes for MHC class II binding and presentation. T cell hybridoma responses and elution of MHC class II bound peptides have identified GILT-dependent epitopes, GILT-independent epitopes, and epitopes that are more efficiently presented in the absence of GILT termed GILT-prevented epitopes. GILT-mediated alteration in the MHC class II-restricted peptidome modulates T cell development in the thymus and peripheral tolerance and influences the pathogenesis of autoimmunity. Recent studies suggest an emerging role for GILT in the response to pathogens and cancer survival.
MHC II类分子限制的抗原加工途径在内吞途径中产生肽:MHC复合物,用于激活CD4(+) T细胞。γ干扰素诱导的溶酶体硫醇还原酶(GILT)可还原内吞区室中的蛋白质二硫键,从而暴露隐藏的表位以用于MHC II类分子结合和呈递。T细胞杂交瘤反应以及MHC II类分子结合肽的洗脱已鉴定出GILT依赖性表位、GILT非依赖性表位以及在没有GILT的情况下更有效地呈递的表位,称为GILT阻止性表位。GILT介导的MHC II类分子限制的肽组改变调节胸腺中的T细胞发育和外周耐受性,并影响自身免疫的发病机制。最近的研究表明,GILT在对病原体的反应和癌症存活中发挥着新出现的作用。